Stella Mental Health Unveils 2026 Impact Report Marking Progress in Patient Recovery
In an insightful celebration of Mental Health Awareness Month, Stella Mental Health has released its 2026 Impact Report, revealing the transformative effects of its comprehensive treatment approaches on a vast patient base of 16,176 individuals since January 2020. The data, collected from their 17 U.S. locations, highlights not only the variety of treatment modalities utilized but also their success in promoting significant clinical improvements in mental health.
The report details a significant distribution of treatments employed at Stella, with 39% of patients receiving Medication Management, 21% opting for the Stellate Ganglion Block, and others benefiting from Spravato, Ketamine Therapy, and Transcranial Magnetic Stimulation (TMS). A notable 9% of patients underwent a combination of treatments, illustrating the clinic's flexible and adaptive approach to care.
Additionally, the report sheds light on the types of trauma reported by patients, revealing an average of more than three different trauma types per individual. Childhood trauma (50%) was the most commonly reported, followed by health-related issues (39%) and loss of a loved one (38%). These diverse backgrounds emphasize the complexity of the cases Stella Mental Health often addresses, as many patients arrive with longstanding issues that previous treatments have not successfully managed.
"Our aim is to offer a comprehensive range of options that cater specifically to the needs of our patients, instead of forcing patients into a single treatment paradigm," stated Dr. Brian Boyle, Chief Psychiatric Officer at Stella Mental Health. He further elaborated on how their mission is not limited to just one aspect of treatment; rather, it is a dedication to ensuring patients receive the individualized and multifaceted care they deserve.
Key findings from the report indicate encouraging success rates among various treatment methods. The Dual Sympathetic Reset (DSR) technique showed an impressive 81% of patients encountering significant improvements or remission from PTSD, marked by a substantial average decrease of 57% in PCL-5 scores. Spravato, a nasal spray treatment, resulted in 68% of users achieving similar improvements in depression with an average PHQ-9 score drop of 51%. Ketamine Therapy and TMS also demonstrated remarkable effectiveness, with 63% and 67% of patients respectively reporting significant improvements.
The data also highlighted the efficacy of combined treatments, where those receiving two interventions showed even more pronounced results, with 87% experiencing significant improvement in PTSD symptoms, underscoring the powerful impact of tailored, multimodal care approaches.
"These findings validate the importance of providing nuanced and adaptive treatment plans, especially for those dealing with complex trauma," asserted Gavin Dawson, Director of Medical Operations. "Understanding that these patients arrive often at their most challenging moments, the significance of seeing quantifiable improvements in their mental health cannot be overstated. We are breaking down barriers and creating new pathways to healing."
The report reinforces the commitment of Stella Mental Health to real outcomes and improvements, encouraging a model of care that is patient-centric, evidence-based, and focused on sustainable change. By continuously evolving their approaches based on data and patient feedback, Stella proves that comprehensive mental health initiatives can lead to meaningful recovery journeys.
Stella Mental Health, recognized for its leading role in interventional psychiatry, continues to expand access across its locations, aiming to reach those battling hard-to-treat symptoms like PTSD, anxiety, and depression. As it looks ahead, the organization remains dedicated to its mission of empowering patients and helping them reclaim their lives through cohesive mental health strategies.
The report details a significant distribution of treatments employed at Stella, with 39% of patients receiving Medication Management, 21% opting for the Stellate Ganglion Block, and others benefiting from Spravato, Ketamine Therapy, and Transcranial Magnetic Stimulation (TMS). A notable 9% of patients underwent a combination of treatments, illustrating the clinic's flexible and adaptive approach to care.
Additionally, the report sheds light on the types of trauma reported by patients, revealing an average of more than three different trauma types per individual. Childhood trauma (50%) was the most commonly reported, followed by health-related issues (39%) and loss of a loved one (38%). These diverse backgrounds emphasize the complexity of the cases Stella Mental Health often addresses, as many patients arrive with longstanding issues that previous treatments have not successfully managed.
"Our aim is to offer a comprehensive range of options that cater specifically to the needs of our patients, instead of forcing patients into a single treatment paradigm," stated Dr. Brian Boyle, Chief Psychiatric Officer at Stella Mental Health. He further elaborated on how their mission is not limited to just one aspect of treatment; rather, it is a dedication to ensuring patients receive the individualized and multifaceted care they deserve.
Key findings from the report indicate encouraging success rates among various treatment methods. The Dual Sympathetic Reset (DSR) technique showed an impressive 81% of patients encountering significant improvements or remission from PTSD, marked by a substantial average decrease of 57% in PCL-5 scores. Spravato, a nasal spray treatment, resulted in 68% of users achieving similar improvements in depression with an average PHQ-9 score drop of 51%. Ketamine Therapy and TMS also demonstrated remarkable effectiveness, with 63% and 67% of patients respectively reporting significant improvements.
The data also highlighted the efficacy of combined treatments, where those receiving two interventions showed even more pronounced results, with 87% experiencing significant improvement in PTSD symptoms, underscoring the powerful impact of tailored, multimodal care approaches.
"These findings validate the importance of providing nuanced and adaptive treatment plans, especially for those dealing with complex trauma," asserted Gavin Dawson, Director of Medical Operations. "Understanding that these patients arrive often at their most challenging moments, the significance of seeing quantifiable improvements in their mental health cannot be overstated. We are breaking down barriers and creating new pathways to healing."
The report reinforces the commitment of Stella Mental Health to real outcomes and improvements, encouraging a model of care that is patient-centric, evidence-based, and focused on sustainable change. By continuously evolving their approaches based on data and patient feedback, Stella proves that comprehensive mental health initiatives can lead to meaningful recovery journeys.
Stella Mental Health, recognized for its leading role in interventional psychiatry, continues to expand access across its locations, aiming to reach those battling hard-to-treat symptoms like PTSD, anxiety, and depression. As it looks ahead, the organization remains dedicated to its mission of empowering patients and helping them reclaim their lives through cohesive mental health strategies.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.